Sleep medication may reduce Alzheimer's-linked protein buildup, study finds

A recent study offers a potential new avenue in the fight against Alzheimer's disease, suggesting that sleep medication could help reduce the accumulation of proteins associated with the condition. Researchers found that using suvorexant, a common medication for insomnia, for two nights led to a slight decrease in beta-amyloid and tau proteins. These proteins are known to build up in the brain and are hallmarks of Alzheimer's disease. The study, conducted at Washington University in St. Louis, observed participants in a sleep clinic. While the findings are intriguing, scientists emphasize that the research was short-term and involved a small group of healthy adults. They caution that it is too early to interpret this as a reason for individuals concerned about Alzheimer's to start taking sleep medication nightly. Long-term use of sleep aids can also lead to dependency and may affect sleep quality, potentially interfering with the deep sleep stages crucial for brain waste clearance. Further research is needed to understand the full implications of sleep medication on Alzheimer's pathology and to determine safe and effective therapeutic strategies.

“

it would be premature for people who are worried about the possible development of Alzheimer's disease to interpret this as a reason to start taking suvorexant every night.